Form 4: ZimVie Inc. Director Karen Matusinec Reports Acquisition of Deferred Share Units and Restricted Stock Units

Director Karen Matusinec reports acquisition of deferred share units and restricted stock units in ZimVie Inc.

Summary

• Karen Matusinec, a director of ZimVie Inc., filed a Form 4 on May 17, 2024, reporting transactions that occurred on May 15, 2024.
• The transactions involve the acquisition of 500 deferred share units and 11,012 restricted stock units.
• The deferred share units were accrued under the ZimVie Inc. Deferred Compensation Plan for Non-Employee Directors and will be settled in shares of common stock within sixty days after cessation of service as a Director.
• The restricted stock units are immediately 100% vested but subject to mandatory deferral until the later of termination of service as a Director or three years after the grant date.
• Following the reported transactions, Matusinec beneficially owns 6,255.864 shares directly and 36,609 restricted stock units.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director suggests confidence in the company's future, but it's a routine transaction.

Positives

• The acquisition of deferred share units and restricted stock units indicates continued alignment of the director's interests with the long-term performance of the company.
• The vesting and deferral terms of the restricted stock units incentivize long-term commitment from the director.

Future Outlook

The deferred share units will be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Comparison to Industry Standards

• Comparing ZimVie's director compensation structure with that of similar medical device companies like Medtronic or Stryker, it's common to see a mix of stock options, restricted stock units, and deferred compensation plans.
• The vesting schedules and deferral periods are generally designed to align executive and director interests with long-term shareholder value.
• The specific terms, such as the three-year deferral for restricted stock units, are within the typical range observed in the industry.

Stakeholder Impact

• The acquisition of shares by a director can be viewed positively by shareholders as it aligns the director's interests with theirs.
• Employees may see this as a sign of confidence in the company's future.

Key Dates